vs

Side-by-side financial comparison of James River Group Holdings, Inc. (JRVR) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

James River Group Holdings, Inc. is the larger business by last-quarter revenue ($151.4M vs $87.2M, roughly 1.7× Schrodinger, Inc.). On growth, Schrodinger, Inc. posted the faster year-over-year revenue change (-1.2% vs -12.1%). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs -10.3%).

James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

JRVR vs SDGR — Head-to-Head

Bigger by revenue
JRVR
JRVR
1.7× larger
JRVR
$151.4M
$87.2M
SDGR
Growing faster (revenue YoY)
SDGR
SDGR
+10.9% gap
SDGR
-1.2%
-12.1%
JRVR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
-10.3%
JRVR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
JRVR
JRVR
SDGR
SDGR
Revenue
$151.4M
$87.2M
Net Profit
$32.5M
Gross Margin
65.7%
Operating Margin
-19.7%
Net Margin
37.3%
Revenue YoY
-12.1%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JRVR
JRVR
SDGR
SDGR
Q1 26
$151.4M
Q4 25
$167.7M
$87.2M
Q3 25
$172.7M
$54.3M
Q2 25
$174.8M
$54.8M
Q1 25
$172.3M
$59.6M
Q4 24
$126.7M
$88.3M
Q3 24
$191.5M
$35.3M
Q2 24
$188.3M
$47.3M
Net Profit
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
$32.1M
$32.5M
Q3 25
$1.0M
$-32.8M
Q2 25
$4.8M
$-43.2M
Q1 25
$9.6M
$-59.8M
Q4 24
$-64.8M
$-40.2M
Q3 24
$-39.4M
$-38.1M
Q2 24
$7.6M
$-54.0M
Gross Margin
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Operating Margin
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
14.6%
-19.7%
Q3 25
1.5%
-84.6%
Q2 25
4.2%
-96.6%
Q1 25
9.3%
-85.5%
Q4 24
-57.0%
-23.5%
Q3 24
-27.1%
-193.9%
Q2 24
10.7%
-111.4%
Net Margin
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
19.1%
37.3%
Q3 25
0.6%
-60.4%
Q2 25
2.7%
-78.8%
Q1 25
5.6%
-100.4%
Q4 24
-51.1%
-45.5%
Q3 24
-20.6%
-108.1%
Q2 24
4.0%
-114.2%
EPS (diluted)
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
$0.59
$0.45
Q3 25
$-0.02
$-0.45
Q2 25
$0.06
$-0.59
Q1 25
$0.16
$-0.82
Q4 24
$-2.44
$-0.55
Q3 24
$-1.10
$-0.52
Q2 24
$0.13
$-0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JRVR
JRVR
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$228.2M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$518.4M
$364.1M
Total Assets
$4.8B
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JRVR
JRVR
SDGR
SDGR
Q1 26
$228.2M
Q4 25
$260.9M
$395.5M
Q3 25
$238.8M
$391.2M
Q2 25
$220.0M
$450.2M
Q1 25
$279.4M
$500.3M
Q4 24
$362.3M
$352.1M
Q3 24
$359.8M
$388.7M
Q2 24
$672.5M
$377.3M
Stockholders' Equity
JRVR
JRVR
SDGR
SDGR
Q1 26
$518.4M
Q4 25
$538.2M
$364.1M
Q3 25
$503.6M
$321.4M
Q2 25
$492.6M
$342.9M
Q1 25
$484.5M
$373.5M
Q4 24
$460.9M
$421.4M
Q3 24
$530.3M
$449.4M
Q2 24
$541.8M
$474.0M
Total Assets
JRVR
JRVR
SDGR
SDGR
Q1 26
$4.8B
Q4 25
$4.9B
$726.2M
Q3 25
$5.0B
$653.7M
Q2 25
$5.0B
$688.2M
Q1 25
$4.9B
$743.0M
Q4 24
$5.0B
$823.2M
Q3 24
$5.0B
$669.3M
Q2 24
$4.7B
$688.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JRVR
JRVR
SDGR
SDGR
Operating Cash FlowLast quarter
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
$-18.8M
$-16.1M
Q3 25
$34.3M
$-61.9M
Q2 25
$25.2M
$-52.2M
Q1 25
$-51.5M
$144.1M
Q4 24
$-247.1M
$-31.1M
Q3 24
$-269.9M
$-33.3M
Q2 24
$-8.7M
$-53.7M
Free Cash Flow
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
$-23.6M
$-16.1M
Q3 25
$33.7M
$-62.4M
Q2 25
$24.7M
$-52.5M
Q1 25
$-52.7M
$143.5M
Q4 24
$-252.0M
$-32.0M
Q3 24
$-270.8M
$-34.6M
Q2 24
$-9.3M
$-54.7M
FCF Margin
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
-14.1%
-18.5%
Q3 25
19.5%
-114.8%
Q2 25
14.1%
-95.9%
Q1 25
-30.6%
240.9%
Q4 24
-198.9%
-36.2%
Q3 24
-141.4%
-98.0%
Q2 24
-4.9%
-115.6%
Capex Intensity
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
2.9%
0.0%
Q3 25
0.4%
0.9%
Q2 25
0.3%
0.6%
Q1 25
0.7%
1.0%
Q4 24
3.9%
1.0%
Q3 24
0.4%
3.8%
Q2 24
0.3%
2.1%
Cash Conversion
JRVR
JRVR
SDGR
SDGR
Q1 26
Q4 25
-0.59×
-0.50×
Q3 25
33.61×
Q2 25
5.29×
Q1 25
-5.38×
Q4 24
Q3 24
Q2 24
-1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JRVR
JRVR

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons